Sii-onco-bcg Uses, Dosage, Side Effects and more
Sii-onco-bcg has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others.
| Trade Name | Sii-onco-bcg |
| Generic | BCG vaccine |
| BCG vaccine Other Names | Bacillus calmette-guerin live antigen, unspecified substrain, Bacillus Calmette–Guérin (BCG) vaccine, BCG, BCG vaccine |
| Type | Injection |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | Hospital Services & Sales |
| Available Country | Pakistan |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Sii-onco-bcg is a vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer.
Sii-onco-bcg is also used to associated treatment for these conditions: Non-Invasive Bladder Urothelial Carcinoma, Recurrent Superficial Bladder Cancer, Tuberculosis (TB), Urothelial Carcinoma Recurrent, Carcinoma in situ of urinary bladder
